Bio-FD&C Co

Bio-FD&C Co Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Bio-FD&C Co (251120.KQ) as of Nov 14, 2026 is 109.19 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 134.14 % — a change of -18.60% (lower).

Cash Conversion

109.19 %

YoY

-18.60%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Bio-FD&C Co is 2025 109.19 % . Cash Conversion Rate (OCF/Net Income) of Bio-FD&C Co was 2024 134.14 % . It decreases by -18.60% lower compared to the previous year.

The Bio-FD&C Co Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
265.60 KRW
Jan 1, 2019
125.96 KRW
Jan 1, 2020
86.02 KRW
Jan 1, 2021
126.80 KRW
Jan 1, 2022
128.55 KRW
Jan 1, 2023
108.27 KRW
Jan 1, 2024
134.14 KRW
Jan 1, 2025
109.19 KRW
The Bio-FD&C Co Cash Conversion history
YEARCash ConversionYoY
109.19 %-18.60%
134.14 %+23.90%
108.27 %-15.78%
128.55 %+1.38%
126.80 %+47.40%
86.02 %-31.70%
125.96 %-52.58%
265.60 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

Cash Conversion Rate (OCF/Net Income) of Bio-FD&C Co is 109.19 % in 2025.

Cash Conversion Rate (OCF/Net Income) of Bio-FD&C Co changed from 134.14 % to 109.19 %, representing a -18.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Bio-FD&C Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Bio-FD&C Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Bio-FD&C Co